Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ultragreen AiSGX:ULG -4.55%22 EBITDA Margin % is 62.70% as of Jun. 2026, which is 7% above its 10-year median of 58.34. GuruFocus rates SGX:ULG with a GF Score™ of 22/100. The stock has 1 warning sign investors should review. Among 664 Healthcare Providers & Services companies, Ultragreen Ai ranks better than 98.34% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Ultragreen Ai's EBITDA for the
six
months ended in Jun. 2026 was $54.7 Mil. Ultragreen Ai's Revenue for the
six
months ended in Jun. 2026 was $87.2 Mil. Therefore, Ultragreen Ai's EBITDA margin for the quarter that ended in Jun. 2026 was 62.70%.
Ultragreen Ai (SGX:ULG) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Ultragreen Ai EBITDA Margin % Related Terms
Ultragreen Ai EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Ultragreen Ai's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGX:ULG vs VEEV, BTSG, HQY: EBITDA Margin % Comparison
For the Health Information Services subindustry, Ultragreen Ai's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ultragreen Ai EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ultragreen Ai's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Ultragreen Ai's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ultragreen Ai (SGX:ULG) has a EBITDA Margin % of 62.70% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ultragreen Ai and its competitors. This is near median its historical median of 58.34. Over the past decade, Ultragreen Ai's EBITDA Margin % has ranged from 57.09 to 67.32. According to the industry distribution chart, Ultragreen Ai ranks #11 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 1.7%.
Is Ultragreen Ai's EBITDA Margin % too high?
Ultragreen Ai's current EBITDA Margin % of 62.70% is near median its 10-year median of 58.34. Over the past 10 years, this metric has ranged from a low of 57.09 to a high of 67.32. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Ultragreen Ai's value of 62.70% is 512.6% above this industry median. Based on the distribution chart, Ultragreen Ai ranks #11 out of 664 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Ultragreen Ai has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Ultragreen Ai's EBITDA Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Ultragreen Ai ranks #11 out of 664 companies for EBITDA Margin %. This places Ultragreen Ai in the top 2% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.24. Ultragreen Ai's value of 62.70% is 512.6% above this benchmark. Historically, Ultragreen Ai's own EBITDA Margin % has ranged from 57.09 to 67.32 over the past decade. While the company's 10-year median is 58.34 vs. the industry median of 10.24, Ultragreen Ai has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ultragreen Ai's current EBITDA Margin % of 62.70% is 512.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ultragreen Ai and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ultragreen Ai's current EBITDA Margin % is 62.70%, which is near median its own 10-year median of 58.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ultragreen Ai stock overvalued right now?
Ultragreen Ai (SGX:ULG) has a current EBITDA Margin % of 62.70%. The current EBITDA Margin % is 62.70%, which is near median its 10-year median of 58.34 and 512.6% above the Healthcare Providers & Services industry median of 10.24. Ultragreen Ai's overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Ultragreen Ai (SGX:ULG), the current EBITDA Margin % is 62.70% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ultragreen Ai Ltd is engaged in the sales of Indocyanine Green (ICG) pharmaceutical products and cardiology Picture Archiving and Communication System (PACS) software and associated products and services. It provides a fluorescence imaging ecosystem designed to support surgeons with real-time perfusion data and visualization capabilities. The company is organised into business units based on its products and services and operates in (a) the Diagnostic Green (DxG) - Americas segment; (b) the DxG - Rest of the World segment; and (c) the UltraLinQ segment. The company generates the maximum of its revenue from the the DxG - Rest of the World segment, which focuses on the sales of ICG vials and related pharmaceutical products.
22GF Score
Get the complete analysis for SGX:ULG
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:ULG has been successfully added to your 
